Rapid high-performance liquid chromatographic method for determination of adefovir in plasma using UV detection: Application to pharmacokinetic studies

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 8, 2011, Pages 477-480

  Foroutan, Seyed Mohsen ^a   Zarghi, Afshin ^a   Shafaati, Alireza ^a   Movahed, Hooman ^b   Khoddam, Arash ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Noor Research and Educational Institute   (Iran)

Author keywords

Adefovir; HPLC; Nucleotide analog reverse transcriptase inhibitor; Pharmacokinetic studies; Plasma concentration

Indexed keywords

ADEFOVIR;

AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET RADIATION;

EID: 80052371604     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296230     Document Type: Article

References (12)

1. Qaqish R., Mattes K., Ritchie D. Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection. Clin Ther. 2009;25:3084-3099
2. Danta M., Dusheiko G. Adefovir dipivoxil: Review of a novel acyclic nucleoside analogue. Int J Clin Pract. 2004;58:877-886 (Pubitemid 39462210)
3. Hughes W., Shenep J., Rodman J., Fridland A., Willoughby R., Blanchard S., et al. Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2000;44:1041-1046 (Pubitemid 30165288)
4. Sparidans R., Veldkamp A., Hoetelman M., Beijnen J. Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde. J Chromatogr B. 1999;736:115-121
5. Cundy K., Barditch-Crovo P., Walker R., Collier A., Ebeling D., Toole J., et al. Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother. 1995;39:2401-2405
6. Naesens L., Balzarini J., De Clercq E. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection. Clin Chem.1992;38:480-485
7. Zhao L., Chen Y., Zhang Y., Yang H., Zhong D. [Determination of adefovir in monkey plasma by liquid chromatographytandem mass spectrometry]. Yao Xue Xue Ba. 2003;38:120-123Chinese.
8. Liu Y., Xu G., Xu C., Garcia L., Lin C., Yeh L. Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl) adenine in human serumby liquid chromatographytandem mass spectrometry. J Chromatogr B. 2004;803:293-298 (Pubitemid 38452450)
9. Chen X., Liu D., Zhu L., Zhong D. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of adefovir in human plasma. Rapid Commun Mass Spectrom. 2005;19:1893-1898 (Pubitemid 40886716)
10. Bi H., Zhong G., Zhuo S., Chen X., Huang M. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: Application to a pharmacokinetic study. Rapid Commun Mass Spectrom.2005;19:2911-2917 (Pubitemid 41454607)
11. Sun D., Wang H., Wang B., Guo R. Development and validation of a sensitive LC-MS/MS method for the determination of adefovir in human serum and urine. J Pharm Biomed Anal. 2006;42:372-378 (Pubitemid 44310897)
12. Xiong Z., Zhang Y., Qin F., Qin T., Yang S., Li F. Hydrophilic interaction liquid chromatography - Tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study. J Chromatogr B. 2010;878:2111-2116